Metropolitan Digital

Men's Weekly


.

Long COVID: How researchers are zeroing in on the self-targeted immune attacks that may lurk behind it

  • Written by Matthew Woodruff, Instructor of Human Immunology, Emory University
Long COVID: How researchers are zeroing in on the self-targeted immune attacks that may lurk behind itApproximately 30% of people who get COVID-19 develop long-term symptoms, or long COVID-19.Boy Anupong/Moment via Getty Images

For almost three years, scientists have raced to understand the immune responses in patients who develop severe COVID-19, with an enormous effort aimed at defining where healthy immunity ends and destructive immunity begins.

I...

Read more: Long COVID: How researchers are zeroing in on the self-targeted immune attacks that may lurk...

Metropolitan republishes selected articles from The Conversation USA with permission

Visit The Conversation to see more